Polpharma, MS Pharma Ink Licensing Agreements for Biosimilars
02 Sep 2025 //
BUSINESSWIRE
MS Pharma Launches Biologics Plant in Saudi Arabia
27 Aug 2025 //
PR NEWSWIRE
Kashiv & MS Pharma Ink MENA License for XOLAIR Biosimilar ADL-018
05 Aug 2025 //
BUSINESSWIRE
MS Pharma becomes Partner for the Commercialization of FYB203, Formycon
14 May 2024 //
PHARMIWEB
Neopharm Labs Acquires MS Pharma
28 Mar 2023 //
CONTRACT PHARMA
MS Pharma acquires Genepharm, expands chronic disease portfolio
23 Apr 2019 //
IN-PHARMANECHNOLOGIST
MS Pharma Announces Acquisition of Genepharm
16 Apr 2019 //
PR NEWSWIRE